News
-
-
PRESS RELEASE
KALRAY ACCÉLÈRE SUR L'IA ET ORGANISE UNE VISIOCONFÉRENCE DESTINÉE À TOUS LES INVESTISSEURS PARTICULIERS LE MERCREDI 12 JUIN 2024 À 18H00
Kalray, leader du Cloud au Edge, annonce un rapprochement majeur avec Pliops pour devenir un leader mondial de l'accélération des données dans l'IA et le stockage -
PRESS RELEASE
Tribeca Lawsuit Loans Expands Services to Provide Litigation Loans for Appeals Cases
Tribeca Lawsuit Loans expands services to include litigation loans for appealed cases, providing financial relief to plaintiffs facing extended legal battles. Non-recourse loans ensure access to justice without financial strain -
-
PRESS RELEASE
Pearl Certification to Incorporate New National Definition of a Zero-Emissions Building in Its Certification Standards
Pearl Certification partners with the U.S. Department of Energy to incorporate the Zero-Emissions Definition into its Certification standards, supporting decarbonization and electrification efforts -
-
PRESS RELEASE
Outlook Therapeutics(R) (NASDAQ:OTLK) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Outlook Therapeutics receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for wet AMD treatment. Watch the 'What This Means' video featuring CEO Russ Trenary -
-
-
PRESS RELEASE
Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy
Sphene Capital GmbH updates Almonty Industries Inc. report, recommending to buy shares due to rising defence spendings driving tungsten demand. Analyzing Almonty's key assets and development projects, a target price of CAD 2.13 is set